C25H27F4N3O3S
525.6 g/mol
APIDanger
Odanacatib
CAS603139-19-1
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Odanacatib is a compound that acts as a selective inhibitor of cathepsin K. It was developed as a pharmaceutical raw material for research into osteoporosis, advancing to late-stage clinical trials before development was discontinued.
pharmaceutical raw material for osteoporosis researchselective cathepsin K inhibitor in laboratory studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 603139-19-1
Related Compounds
ReferenceSame Category
Leucovorin calcium pentahydrate
CAS6035-45-6
pharmaceutical raw material
ReferenceSame Category
6-Hydroxy-3-(propan-2-yl)-2λ⁶,1,3-benzothiadiazine-2,2,4(1H,3H)-trione
CAS60374-42-7
pharmaceutical raw material
ReferenceSame Category
Oxazepam
CAS604-75-1
pharmaceutical raw material
ReferenceSame Category
Desglymidodrine hydrochloride
CAS60407-53-6
pharmaceutical raw material
Safety Reference
Danger
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide
InChIKey
FWIVDMJALNEADT-SFTDATJTSA-N
SMILES
CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F
Synonyms (16)
- Odanacatib (JAN/USAN)
- MK-0822;MK 0822;MK0822
- ODANACATIB [MART.]
- Odanacatib
- Odanacatib (MK-0822)
- Odanacatinib
- odanacatibum